Ukr.Biochem.J. 2013; Volume 85, Issue 6, Nov-Dec, pp. 144-150

doi: http://dx.doi.org/10.15407/ubj85.06.144

Specific silencing of leukemic oncogenes using RNA-interference approach

11.11.2015   Uncategorized   No comments

T. D. Lebedev1, P. V. Spirin1, N. N. Orlova1, A. S. Gornostaeva1, C. Stocking2, V. S. Prassolov1

1Engelghardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia;
2Heinrich-Pette Institute of Experimental Virology and Immunology, Hamburg, Germany;
e-mail: prassolov45@mail.ru

RNA-interference is an effective natural mechanism of post-transcriptional modulation of gene expression. RNA-interference mechanism exists as in high eukaryotes both animals and plants as well in lower eukaryotes and viruses. RNA-interference is now used as a powerful tool in the study of functional gene activity,  and many essential for fundamental biology results were obtained with this approach. Also it is widely believed that RNA-interference could be used in working out of new therapeutic medicine against malignant, infectious and hereditary diseases. One of the main problems of these developments is search of effective methods of siRNA transfer into the target cells. At the present time different sorts of transfections or viral transduction are used for these purposes. The results of comparison of inhibition of expression of oncogene AML-ETO by synthetic siRNA and by recombinant lentiviruses coding for corresponding shRNA are presented in the article.

Keywords: , ,

References:

  1. Vil’gel’m AE, Chumakov SP, Prasolov VS. RNA interference: biology and perspectives of application in biomedicine and biotechnology. Mol Biol. (Mosk). 2006 May-Jun;40(3):387-403. Review. Russian. PubMed
  2. Volkov AA, Kruglova NS, Meschaninova MI, Venyaminova AG, Zenkova MA, Vlassov VV, Chernolovskaya EL. Selective protection of nuclease-sensitive sites in siRNA prolongs silencing effect. Oligonucleotides. 2009 Jun;19(2):191-202. PubMed, CrossRef
  3. Shuey DJ, McCallus DE, Giordano T. RNAi: gene-silencing in therapeutic intervention. Drug Discov Today. 2002 Oct 15;7(20):1040-6. Review. PubMed
  4. Stanisławska J, Olszewski WL. RNA interference–significance and applications. Arch Immunol Ther Exp (Warsz). 2005 Jan-Feb;53(1):39-46. Review. PubMed
  5. Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods. 2002 Feb;26(2):199-213. PubMed
  6. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002 Apr 19;296(5567):550-3. PubMed
  7. Satake N, Maseki N, Kozu T, Sakashita A, Kobayashi H, Sakurai M, Ohki M, Kaneko Y. Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission. Br J Haematol. 1995 Dec;91(4):892-8. PubMed
  8. Peterson LF, Zhang DE. The 8;21 translocation in leukemogenesis. Oncogene. 2004 May 24;23(24):4255-62. Review. PubMed
  9. Kravchenko JE, Ilyinskaya GV, Komarov PG, Agapova LS, Kochetkov DV, Strom E, Frolova EI, Kovriga I, Gudkov AV, Feinstein E, Chumakov PM. Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway. Proc Natl Acad Sci USA. 2008 Apr 29;105(17):6302-7. PubMed, PubMedCentral, CrossRef
Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.